Skip to content

Released May 9, 2016

10-Q filed May 9, 2016, 39 days after period end · 0001162194-16-000206

Q1 2016 · 10-Q
Revenue$29.00M+8.5% vs Q1 2015−5.6% vs Q4 2015
Net Income-$19.88MN/M vs Q1 2015N/M vs Q4 2015
EPS Diluted-$0.69N/M vs Q1 2015N/M vs Q4 2015
Operating Income-$18,869,000N/M
Operating Cash Flow-$7,792,000N/M
Free Cash Flowderived-$8,936,000N/M
Margins · derived
Operating margin-65.1%−12.7 pt vs Q1 2015
Net margin-68.6%−9.0 pt vs Q1 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2016Q1 2015Q1 2014Q1 2013
Revenue$29.00M$26.73M$25.72M$14.54M
Net Income-$19.88M-$15.93M-$15.41M-$3.55M
EPS Diluted-$0.69-$0.56-$0.57-$0.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR